TGF-β signaling plays a crucial role in epithelial to mesenchymal transition (EMT), a process where epithelial cells lose their epithelial characteristics and acquire a mesenchymal phenotype. EMT is essential during development and is also involved in pathological conditions such as fibrosis and cancer progression. TGF-β induces EMT by activating signaling pathways that lead to the reorganization of the cytoskeleton, loss of cell-cell adhesion, and changes in gene expression. Key signaling pathways involved in TGF-β-induced EMT include the Smad pathway, which is activated by TGF-β receptors and leads to the transcriptional regulation of genes involved in EMT. Other non-Smad pathways, such as those involving Erk, JNK, and p38 MAP kinases, also contribute to EMT by regulating cytoskeleton dynamics, cell migration, and gene expression. Additionally, Rho-like GTPases and PI3 kinase/Akt signaling pathways are involved in the regulation of EMT. The transcriptional regulation of EMT is mediated by various transcription factors, including the Snail, ZEB, and bHLH families, which work together to repress epithelial markers and activate mesenchymal genes. EMT is also involved in the development of various tissues and organs, and its dysregulation is associated with diseases such as cancer and fibrosis. Understanding the molecular mechanisms underlying TGF-β-induced EMT is essential for developing therapeutic strategies to prevent or treat diseases associated with EMT.TGF-β signaling plays a crucial role in epithelial to mesenchymal transition (EMT), a process where epithelial cells lose their epithelial characteristics and acquire a mesenchymal phenotype. EMT is essential during development and is also involved in pathological conditions such as fibrosis and cancer progression. TGF-β induces EMT by activating signaling pathways that lead to the reorganization of the cytoskeleton, loss of cell-cell adhesion, and changes in gene expression. Key signaling pathways involved in TGF-β-induced EMT include the Smad pathway, which is activated by TGF-β receptors and leads to the transcriptional regulation of genes involved in EMT. Other non-Smad pathways, such as those involving Erk, JNK, and p38 MAP kinases, also contribute to EMT by regulating cytoskeleton dynamics, cell migration, and gene expression. Additionally, Rho-like GTPases and PI3 kinase/Akt signaling pathways are involved in the regulation of EMT. The transcriptional regulation of EMT is mediated by various transcription factors, including the Snail, ZEB, and bHLH families, which work together to repress epithelial markers and activate mesenchymal genes. EMT is also involved in the development of various tissues and organs, and its dysregulation is associated with diseases such as cancer and fibrosis. Understanding the molecular mechanisms underlying TGF-β-induced EMT is essential for developing therapeutic strategies to prevent or treat diseases associated with EMT.